Theravance Biopharma, Inc. Increase (Decrease) in Due from Related Parties, Current
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Due from Related Parties, Current of $26.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent · last filed 2017-05-10
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for the quarter ending 2017-03-31 was $26.00K.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for the quarter ending 2016-03-31 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for the quarter ending 2015-09-30 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for fiscal 2016 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for fiscal 2015 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for fiscal 2014 was -$14.63M.
- Theravance Biopharma, Inc. increase (decrease) in due from related parties, current for fiscal 2013 was $0.00.
| Period end | Increase (Decrease) in Due from Related Parties, Current 3 month | Increase (Decrease) in Due from Related Parties, Current 6 month | Increase (Decrease) in Due from Related Parties, Current 9 month | Increase (Decrease) in Due from Related Parties, Current 12 month |
|---|---|---|---|---|
| 2017-03-31 | $26.00K 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 | |||
| 2014-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$14.19M derived: sum of 2 quarters · filed 2017-03-01 | -$14.63M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$14.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$14.98M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$449.00K 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 10-K · filed 2016-03-11 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |